Lucas Svetlana
aTyr Pharma, Inc. · Director
Lucas Svetlana is listed in filings as Director at aTyr Pharma, Inc.. This profile follows SEC Form 4 activity through May 13, 2026, including purchase activity. Recent filings connect the profile to aTyr Pharma, Inc. (ATYR) and Jasper Therapeutics, Inc. (JSPR). The current snapshot covers public activity from Jun 20, 2024 to May 13, 2026. Reported amounts are shown as $47.5K to $48.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available. | ||||